Polyvalent Rev decoys act as artificial Rev-responsive elements

Journal of Virology

Volumn 73, Issue 5, 1999, Pages 4341-4349

  Symensma, Tonia L ^a   Baskerville, Scott ^a   Yan, Amy ^b   Ellington, Andrew D ^b  

^a INDIANA UNIVERSITY   (United States)

^b The University of Texas at Austin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REV PROTEIN;

ARTICLE; GENE EXPRESSION REGULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CELL INTERACTION; VIRUS GENE;

EID: 0032901069     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.5.4341-4349.1999     Document Type: Article

References (60)

1. Ausubel, F., R. Brent, R. Kingston, D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1997. Short protocols in molecular biology, 3rd ed. John Wiley & Sons, Inc., New York, N. Y.
2. Bartel, D. P., M. L. Zapp, M. R. Green, and J. W. Szostak. 1991. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67:529-536.
3. Bogerd, H. P., R. A. Fridell, S. Madore, and B. R. Cullen. 1995. Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell 82:485-494.
4. Cook, K. S., G. J. Fisk, J. Hauber, N. Usman, T. J. Daly, and J. R. Rusche. 1991. Characterization of HIV-1 Rev protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res. 19:1577-1583.
5. Cullen, B. R. 1991. Regulation of HIV-1 gene expression. FASEB J. 5:2361-2367.
6. Daly, T. J., R. C. Doten, P. Rennert, M. Auer, H. Jaksche, A. Donner, G. Fisk, and J. R. Rusche. 1993. Biochemical characterization of binding of multiple HIV-1 Rev monomeric proteins to the Rev responsive element. Biochemistry 32:10497-10505.
7. Fischer, U., S. Meyer, M. Teufel, C. Heckel, R. Luhrmann, and G. Rautmann. 1994. Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO J. 13:4105-4112.
8. Fischer, U., J. Huber, W. C. Boelens, I. W. Mattaj, and R. Luhrmann. 1995. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483.
9. Fornerod, M., M. Ohno, M. Yoshida, and I. W. Mattaj. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-1060.
10. Fritz, C. C., M. L. Zapp, and M. R. Green. 1995. A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature 376:530-533.
11. Gerace, L. 1995. Nuclear export signals and the fast track to the cytoplasm. Cell 82:341-344.
12. Giver, L., D. Bartel, M. Zapp, A. Pawul, M. Green, and A. D. Ellington. 1993. Selective optimization of the Rev-binding element of HIV-1. Nucleic Acids Res. 21:5509-5516.
13. Good, P. D., A, J. Krikos, S. X. L. Li, E. Bertrand, N. S. Lee, L. Giver, A. D. Ellington, J. A. Zaia, J. J. Rossi, and D. R. Engelke. 1997. Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther. 4:45-54.
14. Hadzopoulou-Cladaras, M., B. Felber, C. Cladaras, A. Athanassopoulos, A. Tse, and G. N. Pavlakis. 1989. The Rev (Trs/Art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the Env region. J. Virol. 63:1265-1274.
15. Heaphy, S., J. T. Finch, M. J. Gait, J. Karn, and M. Singh. 1991. Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located with the rev response region of viral mRNAs. Proc. Natl. Acad. Sci. USA 88: 7366-7370.
16. Holland, S. M., M. Chavez, S. Gerstberger, and S. Venkatesan. 1992. A specific sequence with a bulged guanosine residue(s) in a stem-bulge-stem structure of Rev-responsive element RNA is required for trans activation by human immunodeficiency virus type 1 Rev. J. Virol. 66:3699-3706.
17. Hope, T. J., D. McDonald, X. Huang, J. Low, and T. G. Parslow. 1990. Mutational analysis of the human immunodeficiency virus type 1 Rev trans-activator: essential residues near the amino terminus. J. Virol. 64:5360-5366.
18. Hope, T. J., X. Huang, D. McDonald, and T. G. Parslow. 1990. Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc. Natl. Acad. Sci. USA 87:7787-7791.
19. Hope, T. J., N. P. Klein, M. E. Elder, and T. G. Parslow. 1992. Trans-dominant inhibition of human immunodeficiency virus type 1 Rev occurs through formation of inactive protein complexes. J. Virol. 66:1849-1855.
20. Hope, T. J. 1997. Viral RNA export. Chem. Biol. 4:335-344.
21. Huang, X., T. J. Hope, B. L. Bond, D. McDonald, K. Gahl, and T. G. Parslow. 1991. Minimal Rev-response element for type 1 human immunodeficiency virus. J. Virol. 65:2131-2134.
22. Inouye, R. T., B. Du, D. Boldt-Houle, A. Ferrante, I.-W. Park, S. M. Hammer, L. Duan, J. E. Groopman, R. J. Pomerantz, and E. F. Terwilliger. 1997. Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector. J. Virol. 71:4071-4078.
23. Iwai, S., C. Pritchard, D. A. Mann, J. Karn, and M. J. Gait. 1992. Recognition of the high affinity binding site in rev-response element RNA by the human immunodeficiency virus type 1 rev protein. Nucleic Acids Res. 20: 6465-6472.
24. Jaeger, J. A., D. H. Turner, and M. Zuker. 1989. Improved predictions of secondary structures for RNA. Proc. Natl. Acad. Sci. USA 86:7706-7710.
25. Jaeger, J. A., D. H. Turner, and M. Zuker. 1990. Predicting optimal and suboptimal secondary structure for RNA. Methods Enzymol. 183:281-306.
26. Junker, U., K. Rittner, M. Homann, D. Bevec, E. Bohnlein, and G. Sczakiel. 1994. Reduction in replication of the human immunodeficiency virus type 1 in human T cell lines by polymerase III-drived transcription of chimeric tRNA-antisense RNA genes. Antisense Res. Dev. 4:165-172.
27. Kjems, J., A. D. Frankel, and P. A. Sharp. 1991. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1. Cell 67:169-178.
28. Kjems, J., B. J. Calnan, A. D. Frankel, and P. A. Sharp. 1992. Specific binding of basic peptide from HIV-1 Rev. EMBO J. 11:1119-1129.
29. Kjems, J., and P. A. Sharp. 1993. The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6-U5 small nuclear ribonucleoprotein in spliceosome assembly. J. Virol. 67:4769-4776.
30. Lee, S.-W., H. F. Gallardo, E. Gilboa, and C. Smith. 1994. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. J. Virol. 68:8254-8264.
31. Lee, T. C., B. A. Sullenger, H. F. Gallardo, G. E. Ungers, and E. Gilboa. 1992. Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells. New Biol. 4:66-74.
32. Lin, Y. S., and M. R. Green. 1989. Similarities between prokaryotic and eukaryotic cyclic AMP-responsive promoter elements. Nature 340:656-659.
33. Malim, M. H., S. Bohnlein, J. Hauber, and B. R. Cullen. 1989. Functional dissection of the HIV-1 Rev trans-activator: derivation of a trans-dominant represser of Rev function. Cell 58:205-214.
34. Malim, M. H., J. Hauber, S.-Y. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338:254-257.
35. Malim, M. H., L. S. Tiley, D. F. McCarn, J. R. Rusche, J. Hauber, and B. R. Cullen. 1990. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 60:675-683.
36. Malim, M. H., and B. R. Cullen. 1991. HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell 65:241-248.
37. Malim, M. H., D. F. McCarn, L. S. Tiley, and B. R. Cullen. 1991. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 65:4248-4254.
38. Mann, D. A., I. Mikaelian, R. W. Zemmel, S. M. Green, A. D. Lowe, T. Kimura, M. Singh, J. G. Butler, M. J. Gait, and J. Karn. 1994. Co-operative rev binding to stem I of the rev-response element modulates human immunodeficiency virus type 1 late gene expression. J. Mol. Biol. 241:193-207.
39. McDonald, D., T. J. Hope, and T. G. Parslow. 1992. Posttranscriptional regulation by the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type 1 Rex proteins through a heterologous RNA binding site. J. Virol. 66:7232-7238.
40. Meyer, B. E., and M. H. Malim. 1994. The HIV-1 Rev trans-activator shuttles between the nucleus and cytoplasm. Genes Dev. 8:1538-1547
41. Molinaro, M., and I. J. Tinoco. 1995. Use of ultra stable UNCG tetraloop hairpins to fold RNA structures: thermodynamic and spectroscopic applications. Nucleic Acids Res. 23:3056-3063.
42. Olsen, H. S., A. W. Cochrane, P. J. Dillon, C. M. Nalin, and C. A. Rosen. 1990. Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes Dev. 4:1357-1364.
43. Parslow, T. G. 1993. Post-transcriptional regulation of human retrovital gene expression, p. 101-136. In B. R. Cullen (ed.), Human retroviruses. Oxford University Press, New York, N. Y.
44. Peterlin, B. M., P. A. Luciw, P. J. Barr, and M. D. Walker. 1986. Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 83:9734-9738.
45. Richard, N., S. Iacampo, and A. Cochrane. 1994. HIV-1 Rev is capable of shuttling between the nucleus and cytoplasm. Virology 204:123-131.
46. Ruhl, M., M. Himmelspach, G. M. Bahr, F. Hammerschmid, H. Jaksche, B. Wolff, H. Aschauer, G. K. Farrington, H. Probst, D. Bevec, and J. Hauber. 1993. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating transactivation. J. Cell Biol. 123:1309-1320.
47. Schatz, O., M. Oft, C. Dascher, M. Schebesta, O. Rosorius, H. Jaksche, M. Dobrovnik, D. Bevec, and J. Hauber. 1998. Interaction of the HIV-1 Rev cofactor eukaryotic initiation factor 5A with ribosomal protein L5. Proc. Natl. Acad, Sci. USA 95:1607-1612.
48. Sczakiel, G., M. Oppenlander, K. Rittner, and M. Pawlita. 1992. Tat- and Rev-directed antisense RNA expression inhibits and abolishes replication of human immunodeficiency virus type 1: a temporal analysis. J. Virol. 66:5576-5581.
49. Stutz, F., E. Izaurralde, I. W. Mattaj, and M. Rosbash. 1996. A role for nucleoporin FG repeat domains in export of human immunodeficiency virus type 1 Rev protein and RNA from the nucleus. Mol. Cell. Biol. 16:7144-7150.
50. Symensma, T. L., L. Giver, M. Zapp, G. B. Takle, and A. D. Ellington. 1996. RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo. J. Virol. 70:179-187.
51. Tuerk, C., and S. MacDougal-Waugh. 1993. In vitro evolution of functional nucleic acids: high-affinity RNA ligands of HIV-1 proteins. Gene 137:33-39.
52. Venkatesan, S., S. M. Gerstberger, H. Park, S. M. Holland, and Y. S. Nam. 1992. Human immunodeficiency virus type 1 Rev activation can be achieved without Rev responsive element RNA if Rev is directed to the target as a Rev/MS2 fusion protein which tethers the MS2 operator RNA. J. Virol. 66:7469-7480.
53. Wen, W., J. L. Meinkoth, R. Y. Tsien, and S. S. Taylor. 1995. Identification of a signal for rapid export of proteins from the nucleus. Cell 82:463-473.
54. Yamada, O., G. Kraus, L. Luznik, M. Yu, and F. Wong-Staal. 1996. A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1. J. Virol. 70:1596-1601.
55. Yuyama, N., J. Ohkawa, T. Koguma, M. Shirai, and K. Taira. 1994. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5′- and 3′-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev. Nucleic Acids Res. 22:5060-5067.
56. Zapp, M. L., and M. R. Green. 1989. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature 342:714-716.
57. Zapp, M. L., T. J. Hope, T. G. Parslow, and M. R. Green. 1991. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc. Natl. Acad. Sci. USA 88:7734-7738.
58. Zemmel, R. W., A. C. Kelley, J. Karn, and P. J. G. Butler. 1996. Flexible regions of RNA structure facilitate co-operative rev assembly on the revresponse element. Mol. Biol. 258:763-777.
59. Zhou, C., I. C. Bahner, G. P. Larson, J. A. Zaia, J. J. Rossi, and D. B. Kohn. 1994. Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 149:33-39.
60. Zuker, M. 1989. On finding all suboptimal foldings of an RNA molecule. Science 244:48-52.